Androgen deprivation therapy is a common and effective treatment for advanced prostate cancer. However, among other side-effects, it can cause significant bone thinning in men on long-term treatment. A new study¹ by Vahakn Shahinian and Yong-Fang Kuo from the Universities of Michigan and Texas...
Androgen suppression - the inhibition of testosterone and other male hormones - is a routine therapy for prostate cancer. Unfortunately, it can dramatically reduce the quality of patients' sex lives and, more importantly, lead to cancer recurrence in a more deadly androgen-independent form. A...
In the online version of Clinical Cancer Research, a group of investigators from Takeda laboratories address androgen signal transduction in castration-resistant prostate cancer (CRPC). They note that despite castrate levels of testosterone, androgens can be measured in the tissues of patients...